MyStart Health
MyStart Health describes ongoing clinician access, refill screening and necessary bloodwork within its weight-management program. Its small self-reported outcomes survey and prescribing-after-checkout sequence deserve equal attention.
Review by Leah Garner, clinical-evidence editor · Updated October 2026
The short version
The stated follow-up is more substantial than a prescription-only transaction. Confirm the actual preparation and treating practice, and resolve the refund cutoff before committing to a longer plan.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
FDA warning letter on record: Letter 714755 · September 2025
MyStart Health is a technology platform arranging weight-management care through independent clinicians and pharmacies. The website describes compounded GLP-1 treatment rather than a guaranteed approved-brand prescription. It advertises an inclusive program with medical evaluations, continuing clinical access, necessary testing and pharmacy coordination. A short prequalification screen is only the first step. Its medical disclosure says the actual prescribing consultation comes after checkout and remains an independent provider decision. That sequence matters when choosing a service: the initial payment does not itself establish the treatment or the clinical relationship.
Treatment details to confirm
The public program does not identify an eligible named peptide and formulation for comparison. Confirm the actual prescription, preparation and treating practice before choosing a program.
Who prescribes
A licensed clinician
The platform operator is MyStart Health LLC. The homepage names Dr. Ritu Chopra as chief medical adviser, which is a leadership reference rather than identification of every treating clinician. The assigned doctor and medical practice still need confirmation. The website describes a network of U.S.-licensed providers but does not identify the individual responsible for each public offer. Ask who reviews the history, handles later dose questions and covers messages when that clinician is unavailable. A named adviser should not be assumed to conduct the routine appointment or supervise every prescription personally.
Patients complete a health intake for review and may have a video consultation when needed. The public FAQ says a prescription decision can sometimes follow the information review without a live visit. It also describes same-day video availability when necessary. Continuing clinician access is advertised as unlimited without an additional consultation charge. Refill screening is required every three months, and patients are asked to provide current weight, blood pressure and heart-rate information before visits. This gives a clearer description of ongoing care than an initial eligibility quiz alone. Ask how quickly a new symptom reaches the treating professional.
Are labs required?
Included
The homepage FAQ says necessary bloodwork is included in the program. That is useful, but it does not publish the exact panel or testing schedule for every treatment. Ask which baseline reports are needed, whether existing results are accepted and how the clinician follows up an abnormal result. The service also asks for current weight, blood pressure and heart rate before visits. These home measurements are distinct from laboratory testing. Confirm whether a local visit will be needed if a symptom or test result cannot be assessed adequately through remote care.
Ready to start with MyStart Health?
Prices and plans are set on the seller's own site.
What it claims, and what it cites
The site describes substantial weight-loss potential, but its disclosure identifies a survey of only sixteen customers behind some outcomes and satisfaction claims. Those were self-reported experiences within a program that included clinical guidance. They cannot establish what a broader patient population will experience. FDA’s September 9, 2025 warning to MyStart Health challenged compounded semaglutide advertising that implied approved generic status or equivalent results. The current disclosures acknowledge the lack of FDA approval for compounded preparations. Read that dated action alongside the present explanation, without assuming a particular current prescription or batch was evaluated by FDA.
How it bills
The general program starts at $299 per month before discounts, according to the homepage FAQ. That amount includes several services, but is not tied to one universal publicly identified prescription. Monthly and three-month billing structures are described separately, with the longer supply shipped together. Cancellation requires contacting support and receiving confirmation. The refund policy describes a pre-fulfillment cancellation exception, then separately excludes refunds once a prescription has been written. That leaves a meaningful boundary to clarify before the consultation. Medical ineligibility without a prescription or shipment is described as eligible for a full refund.
For and against
- For: Unlimited continuing clinician access described
- For: Necessary bloodwork listed as included
- For: Regular refill screening and measurements explained
- For: Outcome survey size disclosed
- Against: Prescribing consultation follows checkout
- Against: Sixteen-person survey cannot establish typical results
- Against: Treating practice and dispenser need confirmation
- Against: Refund cutoff language needs clarification
Right for
Someone who values continuing clinician access and testing inclusion, and will establish the actual prescription and financial commitment before proceeding.
Look elsewhere if
A patient expecting a named medicine from the general program price or treating testimonials as a reliable prediction of personal results.
MyStart Health
Frequently asked questions
- Does Dr. Ritu Chopra necessarily conduct the appointment?
- The site identifies him as chief medical adviser. That role does not identify the clinician assigned to an individual patient.
- Is follow-up limited to the first prescription?
- The program describes unlimited clinician access and a refill screening form every three months, with current measurements needed before visits.
- Are necessary blood tests included?
- The homepage FAQ says they are included. Confirm the actual panel, accepted outside results and how any abnormal finding will be managed.
- How strong is the advertised outcomes survey?
- The disclosure describes sixteen self-reporting customers. That is a small, selected group rather than evidence establishing typical results for all patients.
Sources
- Current care program, survey disclosure and included services
- Clinical follow-up and intake questions
- Company and service agreement
- Medical ineligibility and conflicting cancellation cutoffs
- FDA warning dated September 9, 2025
See what MyStart Health prescribes today
MyStart Health sets its own prices, plans and the states it serves. Check them before you start.